Appia Bio logo

Appia Bio

Los Angeles, CA

Appia Bio is an early-stage biotechnology company based in Los Angeles, California. Appia Bio is focused on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

appiabio.com

Company Details

Founded

2020

Employees

Between 20 - 50 employees

Raised

$52,000,000

Headquarters Location

Los Angeles, CA

Public

No

Acquired

No

CEO

JJ KangJJ Kang

Founders

Pin Wang
Pin Wang
Lili Yang
Lili Yang
David Baltimore
David Baltimore
JJ Kang
JJ Kang

Company Collections

These are collections Appia Bio is a part of. Click on the collection name to view similar companies.

Appia Bio's Tech Stack

Appia Bio's Investors

Company Collections For Appia Bio